ZA909305B - Heterocyclic carboxylic acids - Google Patents

Heterocyclic carboxylic acids

Info

Publication number
ZA909305B
ZA909305B ZA909305A ZA909305A ZA909305B ZA 909305 B ZA909305 B ZA 909305B ZA 909305 A ZA909305 A ZA 909305A ZA 909305 A ZA909305 A ZA 909305A ZA 909305 B ZA909305 B ZA 909305B
Authority
ZA
South Africa
Prior art keywords
image
carboxylic acids
alkyl
alkoxy
substituted
Prior art date
Application number
ZA909305A
Other languages
English (en)
Inventor
Knud Erik Andersen
Erik Andersen Knud
Lars Jacob Stray Knudsen
Jacob Stray Knudsen Lars
Ursula Sonnewald
Sonnewald Ursula
Per Olaf Sorensen
Olaf Sorensen Per
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA909305B publication Critical patent/ZA909305B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA909305A 1989-11-22 1990-11-20 Heterocyclic carboxylic acids ZA909305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer

Publications (1)

Publication Number Publication Date
ZA909305B true ZA909305B (en) 1991-09-25

Family

ID=8145900

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909305A ZA909305B (en) 1989-11-22 1990-11-20 Heterocyclic carboxylic acids

Country Status (16)

Country Link
US (1) US5198451A (xx)
EP (1) EP0502031B1 (xx)
JP (1) JPH05503083A (xx)
AT (1) ATE157086T1 (xx)
AU (1) AU660919B2 (xx)
CA (1) CA2073189C (xx)
DE (1) DE69031312T2 (xx)
DK (2) DK588189D0 (xx)
FI (1) FI97541C (xx)
IE (1) IE904155A1 (xx)
IL (2) IL96370A (xx)
NO (1) NO177853C (xx)
NZ (1) NZ236155A (xx)
PT (1) PT95970B (xx)
WO (1) WO1991007389A1 (xx)
ZA (1) ZA909305B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
ES2297859T3 (es) * 1996-05-24 2008-05-01 Smithkline Beecham Corporation Uso de inhibidores de la captacion de gaba como agentes antitusivos.
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE3787657T2 (de) * 1986-01-07 1994-02-03 Novo Ind A S Bagsvaerd Aminosäure-Derivate.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
NO921852L (no) 1992-05-11
FI97541B (fi) 1996-09-30
DE69031312D1 (de) 1997-09-25
NZ236155A (en) 1993-04-28
PT95970A (pt) 1991-09-13
ATE157086T1 (de) 1997-09-15
IL96370A (en) 1995-01-24
EP0502031A1 (en) 1992-09-09
DK0502031T3 (da) 1998-03-30
AU6746490A (en) 1991-06-13
US5198451A (en) 1993-03-30
FI97541C (fi) 1997-01-10
CA2073189A1 (en) 1991-05-23
DK588189D0 (da) 1989-11-22
AU660919B2 (en) 1995-07-13
FI922268A0 (fi) 1992-05-19
FI922268A (fi) 1992-05-19
CA2073189C (en) 1998-04-07
NO177853B (no) 1995-08-28
PT95970B (pt) 1998-01-30
WO1991007389A1 (en) 1991-05-30
NO921852D0 (no) 1992-05-11
NO177853C (no) 1995-12-06
IE904155A1 (en) 1991-05-22
IL96370A0 (en) 1991-08-16
JPH05503083A (ja) 1993-05-27
EP0502031B1 (en) 1997-08-20
DE69031312T2 (de) 1998-02-26

Similar Documents

Publication Publication Date Title
DE59401923D1 (de) Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
IL87795A (en) Benzimidazolin-2-oxo- 1-carboxylic acid ester and amide derivatives, their preparation and pharmaceutical compositions containing them
ZA934997B (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives
MX9707531A (es) Nuevos compuestos heterociclicos.
JP2005504729A5 (xx)
EP0344682A3 (de) Oligopeptide mit zyklischen Prolin-analogen Aminosäuren
ATE285403T1 (de) Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen
ZA909305B (en) Heterocyclic carboxylic acids
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
PL233059A1 (xx)
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
HU895648D0 (en) Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds
KR960704888A (ko) AMPA-수용체에 작용하는 알콕시-치환 β-카르보린 (Alkoxy-Substituted β-Carbolines Acting on The AMPA-Receptor)
NO903927D0 (no) N-azabicyklo(3.3.0)oktan-amider av aromatiske syrer.
NZ331180A (en) Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
ATE229495T1 (de) Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen